Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 685.33B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Gilead Sciences (GILD) , Celgene (CELG).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 116.14B 15.45 -2.49% 2.31%
Biogen Inc (BIIB)
4.3/5 61.48B 15.99 -4.96% 4.88%
Anika Therapeutics (ANIK)
4.2/5 731.59M 21.49 -1.42% 35.3%
Gilead Sciences (GILD)
4.2/5 96.27B 6.67 -4.13% -20.01%
Celgene (CELG)
3.9/5 91.07B 43.54 -4.19% 11.61%
Regeneron Pharma (REGN)
3.9/5 38.83B 53.81 -2.62% -18.74%
AMAG Pharma (AMAG)
3.9/5 786.83M 59.87 1.08% 4.24%
China Biologic Products (CBPO)
3.9/5 2.96B 28.61 -5.94% -17.92%
Cambrex (CBM)
3.8/5 1.8B 28.75 -3.48% 35.57%
PDL BioPharma (PDLI)
3.8/5 375.78M 2.12 -3.85% -25.5%
Myriad Genetics (MYGN)
3.8/5 1.12B 13.75 -9.55% -60.53%
Enzo Biochem (ENZ)
3.7/5 329.12M 8.18 -4.45% 48.7%
Alexion Pharma (ALXN)
3.7/5 30.66B 83.01 -5.83% -13.68%
Emergent Biosolutions (EBS)
3.6/5 1.24B 30.30 -3.51% -9.09%
Innoviva (INVA)
3.6/5 1.23B 32.00 -5.39% 29.99%
Incyte (INCY)
3.6/5 22.18B 145.69 -4.74% 55.01%
BioTechne Corporation (TECH)
3.6/5 3.78B 37.81 -4.76% 20.58%
Illumina (ILMN)
3.6/5 23.88B 53.67 -2.77% -5.37%
Five Prime Therapeutics (FPRX)
3.3/5 1.39B 5.32 -8.25% 46.86%
Integra LifeSciences (IART)
3.3/5 3.18B 55.16 -5.41% 34.48%
Qiagen (QGEN)
3.3/5 6.8B 56.51 -3.28% 24.79%
Horizon Pharma (HZNP)
3.3/5 2.81B - -7.41% -5.47%
ANI Pharma (ANIP)
3.3/5 688.89M 84.25 -4.99% 71.58%
Repligen (RGEN)
3.3/5 1.05B 148.55 -7.7% 38.77%
Ligand Pharma (LGND)
3.2/5 2.21B 298.41 -7.23% 7.09%
Applied Genetic Technologies (AGTC)
3.2/5 169.84M 14.21 -10.95% -37.93%
Osiris Therapeutics (OSIR) 3.1/5 169.16M 78.00 -2.63% -31.38%
Heska (HSKA)
3.1/5 531.77M 61.03 0.46% 122.81%
MiMedx (MDXG)
3.0/5 960.45M 46.17 -4.7% 2.09%
NeoGenomics (NEO)
2.7/5 675.21M - -5.73% 23.02%
Exelixis (EXEL)
2.6/5 5.3B - -5.92% 328.67%
Retrophin (RTRX)
2.6/5 736.91M - -4.43% 19.2%
Vertex Pharma (VRTX)
2.5/5 20.63B - -1.66% -14.15%
Cytokinetics (CYTK)
2.5/5 481.3M - -13.04% 34.8%
Genomic Health (GHDX)
2.4/5 979.26M - -5.25% -6.2%
Alkermes (ALKS)
2.4/5 8.43B - -6.72% -8.35%
Seattle Genetics (SGEN)
2.4/5 8.37B - -2.19% 63.1%
Acorda Therapeutics (ACOR)
2.4/5 986.84M - -3.98% -45.41%
Vanda Pharmaceuticals (VNDA)
2.4/5 626.24M - -9.12% 56.58%
BioMarin Pharma (BMRN)
2.3/5 14.95B - -5.74% 7.17%
Lexicon Pharma (LXRX)
2.3/5 1.53B - -3.92% 46.4%
Kamada (KMDA)
2.3/5 223.07M - 3.78% 62.07%
Amarin (AMRN)
2.2/5 815.26M - -3.63% 105.63%
Organovo (ONVO)
2.2/5 384.3M - -7.31% 105.2%
Halozyme Therapeutics (HALO)
2.2/5 1.47B - -15.52% 19.15%
Array BioPharma (ARRY)
2.2/5 1.83B - 15.28% 250.16%
Galapagos (GLPG)
2.1/5 3.2B - -0.75% 33.15%
Geron (GERN)
2.1/5 335.8M - -7.27% -31.31%
EXACT Sciences (EXAS)
2.1/5 2.06B - 5.69% 196.65%
Momenta Pharma (MNTA)
2.1/5 1.15B - -7.12% 17.55%
Sinovac Biotech (SVA)
2.1/5 342.35M - -0.33% 18.69%
Nymox Pharmaceutical (NYMX)
2.1/5 138.56M - 5.8% 44.19%
Cellectis (CLLS)
2.1/5 639.19M - -3.93% -19.49%
Keryx Biopharma (KERX)
2.1/5 663.31M - -2.9% 89.91%
Coherus Biosciences (CHRS)
2.1/5 1.19B - -10% 66.89%
Aduro BioTech (ADRO)
2.1/5 826.34M - -2.48% -39.08%
VIVUS (VVUS)
2.0/5 125.81M - -4.03% 21.43%
Regenxbio (RGNX)
2.0/5 517.68M - -0.77% 49.34%
Uniquire (QURE)
2.0/5 150.36M - -3.29% -60.14%
Inovio Pharma (INO)
2.0/5 516.95M - -6.69% 36.18%
Athersys (ATHX)
2.0/5 129.1M - -2.6% 36.36%
Arna Pharma (ARNA)
2.0/5 345.63M - -4.17% -10.97%
Curis (CRIS)
1.9/5 417.43M - -10.86% 58.52%
NewLink Genetics (NLNK)
1.9/5 350.2M - -14.01% -56.79%
Compugen (CGEN)
1.9/5 254.54M - -5.77% -0.2%
Alnylam Pharma (ALNY)
1.8/5 3.57B - -14.52% -47.22%
Sorrento Therapeutics (SRNE)
1.8/5 287.49M - -9.32% -2.9%
Celldex Therapeutics (CLDX)
1.8/5 435.01M - -11.11% -66.48%
Evogene (EVGN)
1.8/5 140.91M - 0.57% -25.87%
The Medicines Company (MDCO)
1.8/5 2.7B - 1.81% 19.3%
Arbutus Biopharma (ABUS)
1.8/5 164.53M - 0 -18.1
Intercept Pharma (ICPT)
1.8/5 2.84B - 7.54% -0.58%
Acceleron Pharma (XLRN)
1.8/5 963.68M - -7.45% -23.92%
Spark Therapeutics (ONCE)
1.8/5 1.76B - -12.72% 97.31%
Immunomedics (IMMU)
1.7/5 428.01M - 9.58% 113.74%
Merrimack Pharma (MACK)
1.7/5 416.07M - -10.29% -48.91%
Juno Therapeutics (JUNO)
1.7/5 2.12B - -7.2% -39.98%
Cellular Biomedicine (CBMG)
1.7/5 186.69M - -1.89% 7.2%
Stemline Therapeutics (STML)
1.7/5 248.11M - -13.26% 151.56%
Mesoblast (MESO)
1.7/5 500.41M - 0.16% 22.81%
Blueprint Medicines (BPMC)
1.7/5 1.05B - -1.92% 83.82%
Kite Pharma (KITE)
1.7/5 2.47B - -8.27% -13.5%
Ophthotech (OPHT)
1.7/5 173.49M - -7.99% -92.16%
ZIOPHARM Oncology (ZIOP)
1.6/5 798.3M - -0.86% 5.67%
Cara Therapeutics (CARA)
1.6/5 311.57M - 0.45% 2.01%
Idera Pharma (IDRA)
1.6/5 233.29M - -6.79% -15.64%
Agenus (AGEN)
1.6/5 356.35M - -3.89% 30.36%
Adverum (ADVM)
1.6/5 131.41M - 1.67% -46.96%
Acadia Pharma (ACAD)
1.6/5 3.85B - -0.38% 38.35%
CytomX Therapeutics (CTMX)
1.6/5 421.9M - 0.53% -9.44%
bluebird bio (BLUE)
1.6/5 2.71B - -4.76% 55.35%
Achillion Pharma (ACHN)
1.5/5 574.06M - -8.05% -43.62%
Argos Therapeutics (ARGS)
1.5/5 222.82M - -8.11% 136.11%
Prothena (PRTA)
1.5/5 1.74B - -10.58% 9.32%
OncoMed Pharma (OMED)
1.5/5 298.22M - -12.8% -50.45%
Abeona Therapeutics (ABEO)
1.5/5 211.79M - -10.34% 83.75%
Epizyme (EPZM)
1.5/5 661.33M - -12.5% 9.72%
Revance (RVNC)
1.5/5 624.48M - -11.26% -12.99%
Dynavax Technologies (DVAX)
1.4/5 167.6M - 0 -79.7
Vtv Therapeutics (VTVT)
1.4/5 176.86M - -0.38% -20.42%
Sangamo BioSciences (SGMO)
1.4/5 310.75M - 12.33% -31.44%
Pluristem Therapeutics (PSTI)
1.4/5 126.39M - -4.51% 90.99%
Dimension Therapeutics (DMTX)
1.4/5 120.21M - -3.3% -47.05%
MediciNova (MNOV)
1.4/5 214.7M - 2.68% 66.3%
NantKwest (NK)
1.4/5 532.14M - -5.49% -46.69%
MyoKardia (MYOK)
1.3/5 429.01M - -8.12% 19.83%
Adaptimmune Therapeutics (ADAP)
1.3/5 320.66M - 6.49% -41.86%
Sarepta Therapeutics (SRPT)
1.3/5 2.07B - -4.65% 168.82%
Ascendis Pharma (ASND)
1.3/5 657.61M - 1.98% 27.91%
Xenon Pharma (XENE) 1.3/5 149.41M - -2.96% 13.73%
MannKind (MNKD)
1.3/5 327.83M - 5.75% -12.82%
Alder BioPharma (ALDR)
1.3/5 1.07B - -3.58% -23.17%
Insmed (INSM)
1.3/5 952.92M - 2.93% 9.75%
Amicus Therapeutics (FOLD)
1.3/5 849.02M - -5.09% -20.32%
Paratek Pharma (PRTK)
1.3/5 349.6M - -9.38% -4.42%
Novavax (NVAX)
1.3/5 387.88M - -4.2% -77.43%
Advaxis (ADXS)
1.3/5 370.56M - 6.91% 27.64%
Trevena (TRVN)
1.2/5 356M - -4.31% -18.29%
Beigene (BGNE)
1.2/5 1.03B - 4.45% 16.14%
Intra-Cellular Therapies (ITCI)
1.1/5 645.99M - -14.26% -68.18%
Tengion (TNGNQ) - 0.06M - 100 0
Bionovo (BNVIQ) - 0.02M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.25M - 50% -25%
Viralytics (VRACY) - 160.99M - 0 36.73
Cormedix (CRMD) - 72.77M - -3.87% 37.01%
Williston Holding (WHCA) - 3.93M - 0 900
Neuro Hitech (NHPI) - 0M - 0 0
Igene Biotechnology (IGNE) - 1.1M - 0 0
IR Biosciences (IRBS) - 0M - 0 -100
Advanced Life Sciences (ADLS) - 0M - 0 -100
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 357.74M 15.71 -8.84% 33.06%
Palatin Technologies (PTN) - 58.85M - -16.99% -17.31%
Regenicin (RGIN) - 21.33M - 5.63% 837.5%
Genitope (GTOPQ) - 0.06M - 0 0
ZYTO Corp (ZYTO) - 1.25M - 16.67% 16.67%
Mast Therapeutics (MSTX) - 34.93M - -11.54% -64.97%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.85M - 0 0.64
USA Equities Corp (USAQ) - 0.03M - 0 -97.5
Marina Biotech (MRNA) - 15.25M - -14.29% -20.63%
AtheroNova (AHROQ) - 0.08M - 0 50
Nanobac Pharma (NNBP) - 0.07M - 0 0
Asterias Biotherapeutics (AST) - 226.43M - -1.03% 84.62%
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Bellus Health (BLUSF) - 12.46M - -4.23% -71.43%
Oncolytics Biotech (ONCYF) - 26.93M - -5.5% -23.7%
Protalix Biotherapeutics (PLX) - 42.97M - 11.38% -45.24%
Redpoint Bio (RPBC) - 0.07M - 0 -50
Health Discovery (HDVY) - 1.9M - -41.67% -86%
Respirerx Pharma (RSPI) - 7.98M - -2.5% -44.03%
NeurogesX (NGSX) - 0.17M - -37.5% 66.67%
HedgePath Pharma (HPPI) - 141.37M - 7.89% 310%
iBio (IBIO) - 35.64M - -5% -32.74%
Amarillo (AMAR) - 5.99M - -8.21% 60.63%
Myrexis (MYRX) - 1.52M - 7.32% -50.56%
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 101.29M - -5.15% -45.46%
PROTAGENIC THER (PTIX) - 51.31M - -35.33% 61.71%
Immune Therapeutics (IMUN) - 12.95M - 10.2% -74.29%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.01M - 0 0
Response Genetics (RGDXQ) - 0.05M - 0 -50
Genmab (GNMSF) - 10.92B 108.38 0 44.8
Cel-Sci Corporation (CVM) - 23.97M - -21.38% -73.35%
Nicox (NICXF) - 257.55M - 0 3.1
Pfenex (PFNX) - 211.23M 24.58 -19.7% -15.24%
Interleukin Genetics (ILIU) - 25.05M - 18% 114.55%
US Stem Cell (USRM) - 0.14M - 150% -99.47%
International Stem Cell Corp (ISCO) - 4.05M - -8.26% -60.16%
Affymax (AFFY) - 2.21M - -3.33% -28.4%
Theratechnologies (THERF) - 160.47M 284.00 1.29% 136.17%
BioForce Nanosciences (BFNH) - 0.28M - 0 -54.17
Capstone Therapeutics Corp. (CAPS) - 3.88M - -6% -14.55%
Pathfinder Cell (PFND) - 0.67M - -50% -66.67%
Provectus Biopharma (PVCT) - 4.27M - 0 -95.33
Regenerx Biopharma (RGRX) - 33.1M - 0 -19.8
Guangzhou Pharma (GZPHY) - 726.88M - 0 0
VG Life Sciences (VGLS) - 0.78M - 0 -63.16
Clovis Oncology (CLVS) - 2.46B - 11.67% 157.96%
Volitionrx (VNRX) - 112.98M - -10.17% 20.45%
DNAPrint Genomics (DNAG) - 0.06M - 0 0
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Taxus Cardium Pharma (CRXM) - 2.46M - 9.09% -34.55%
GeneLink (GNLKQ) - 0.21M - 0 0
Nutra Pharma (NPHC) - 2.22M 1.29 0 -70
Atara Bio (ATRA) - 427.14M - -15.66% -23.54%
ImmunoCellular Therapeutics (IMUC) - 9.52M - -38.33% -73.13%
DBV Tech (DBVT) - 1.72B - -1.19% 38.16%
ARYx Therapeutics (ARYX) - 0.13M - 0 33.33
Arbutus Biopharma (ABUS)
- 164.53M - 0 -18.1
Actelion (ALIOF) - 24.8B - -1.35% 81.29%
Prodite Pharma (PPMD) - 0.12M - 0 20
Ampliphi Biosciences (APHB) - 5.67M - -4.08% -79.74%
Quick-Med Technologies (QMDT) - 0.29M - 0 -33.33
SCOLR Pharma (SCLR) - 0.04M - N/A N/A